Evaluation of Abdominal Wall Block With Liposomal Bupivacaine for Post-Operative Analgesia in Donor Nephrectomy
Phase of Trial: Phase IV
Latest Information Update: 14 Dec 2018
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 04 Dec 2018 Planned End Date changed from 1 Feb 2020 to 31 Jan 2020.
- 04 Dec 2018 Planned primary completion date changed from 1 Oct 2019 to 31 Dec 2019.
- 04 Dec 2018 Status changed from not yet recruiting to recruiting.